Article thumbnail

Temporal Dynamics of Host Molecular Responses Differentiate Symptomatic and Asymptomatic Influenza A Infection

By Yongsheng Huang, Aimee K. Zaas, Arvind Rao, Nicolas Dobigeon, Peter J. Woolf, Timothy Veldman, N. Christine Øien, Micah T. McClain, Jay B. Varkey, Bradley Nicholson, Lawrence Carin, Stephen Kingsmore, Christopher W. Woods, Geoffrey S. Ginsburg and Alfred O. Hero


Exposure to influenza viruses is necessary, but not sufficient, for healthy human hosts to develop symptomatic illness. The host response is an important determinant of disease progression. In order to delineate host molecular responses that differentiate symptomatic and asymptomatic Influenza A infection, we inoculated 17 healthy adults with live influenza (H3N2/Wisconsin) and examined changes in host peripheral blood gene expression at 16 timepoints over 132 hours. Here we present distinct transcriptional dynamics of host responses unique to asymptomatic and symptomatic infections. We show that symptomatic hosts invoke, simultaneously, multiple pattern recognition receptors-mediated antiviral and inflammatory responses that may relate to virus-induced oxidative stress. In contrast, asymptomatic subjects tightly regulate these responses and exhibit elevated expression of genes that function in antioxidant responses and cell-mediated responses. We reveal an ab initio molecular signature that strongly correlates to symptomatic clinical disease and biomarkers whose expression patterns best discriminate early from late phases of infection. Our results establish a temporal pattern of host molecular responses that differentiates symptomatic from asymptomatic infections and reveals an asymptomatic host-unique non-passive response signature, suggesting novel putative molecular targets for both prognostic assessment and ameliorative therapeutic intervention in seasonal and pandemic influenza

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.
  2. (2004). A global test for groups of genes: testing association with a clinical outcome.
  3. (2009). A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection.
  4. (1997). A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.
  5. (1996). Activation of a human Ste20-like kinase by oxidant stress defines a novel stress response pathway.
  6. (2009). Activation of innate immune antiviral responses by Nod2.
  7. (2005). Adenovirus-mediated gene transfer of superoxide dismutase and catalase decreases restenosis after balloon angioplasty.
  8. (2006). Antiinflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent.
  9. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14: 778–809, table of contents.
  10. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease.
  11. (2006). Augmented IL-7 signaling during viral infection drives greater expansion of effector T cells but does not enhance memory.
  12. (2007). Boosting algorithms: regularization, prediction and model fitting.
  13. (2003). Boosting with the L2 loss: regression and classification.
  14. (1979). Bootstrap Methods: Another Look at the Jackknife. The Annals of Statistics 7: 1–26. Temporal Host Molecular Responses to Influenza A
  15. (2006). Cell-type specific gene expression profiles of leukocytes in human peripheral blood.
  16. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing.
  17. (2008). Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway.
  18. (2003). Cytokine control of memory T-cell development and survival.
  19. (2006). Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis.
  20. (1997). Elia A
  21. (2002). Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation.
  22. (2006). Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
  23. (2006). Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens.
  24. (2008). Gene expression profiles during in vivo human rhinovirus infection: insights into the host response.
  25. (2009). Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans.
  26. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
  27. (2009). Hero A
  28. (1999). Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps.
  29. (2001). Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.
  30. (2009). Inflammatory Bowel Disease.
  31. (2004). Influenza: old and new threats.
  32. (2005). Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
  33. (2004). Interferon-alpha induction through Toll-like receptors involves a direct interaction of
  34. (2004). Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load.
  35. (2005). IRF-7 is the master regulator of type-I interferon-dependent immune responses.
  36. (2009). Iwasaki A
  37. (2010). Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.
  38. (2009). Lethal influenza virus infection in macaques is associated with early dysregulation of Temporal Host Molecular Responses to Influenza A
  39. (2004). Linear Models with R.
  40. (2002). mda5: An interferon-inducible putative RNA helicase with double-stranded RNAdependent ATPase activity and melanoma growth-suppressive properties.
  41. (2005). NLRs join TLRs as innate sensors of pathogens.
  42. (2009). NOD-like receptors: role in innate immunity and inflammatory disease.
  43. (2005). Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.
  44. (2008). On the coefficient of determination for mixed regression models.
  45. (1996). Oxidative stress during viral infection: a review.
  46. (1989). Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymerconjugated SOD.
  47. (2004). Pareto-optimal methods for gene ranking.
  48. (2006). Pathogen recognition and innate immunity.
  49. (2006). Relations among questionnaire and laboratory measures of rhinovirus infection.
  50. (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
  51. (2005). Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond)
  52. (2009). Role of statins in preventing death among patients hospitalized with labconfirmed influenza infections.
  53. (1995). Self-Organizing Maps.
  54. (2005). Significance analysis of time course microarray experiments.
  55. (2002). Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.
  56. (2008). SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag.
  57. (2008). STAT4: genetics, mechanisms, and implications for autoimmunity.
  58. (2006). Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity.
  59. (2007). TAM receptors are pleiotropic inhibitors of the innate immune response.
  60. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proILbeta.
  61. (2009). The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.
  62. (1997). The PKR protein kinase–an interferon-inducible regulator of cell growth and differentiation.
  63. (2004). The RNA helicase RIG-I has an essential function in double-stranded RNAinduced innate antiviral responses.
  64. (2004). The role of complement in the development of systemic lupus erythematosus.
  65. (2004). The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter.
  66. (2008). Time lines of infection and disease in human influenza: a review of volunteer challenge studies.
  67. (2007). TLR signaling.
  68. (2008). Tolllike receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines.
  69. (1958). Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity.
  70. (2006). Type I interferons in host defense.
  71. (2000). Yoshimura A